Differential Efficacy of Immune Checkpoint Inhibitors due to Age and Sex Factors

  • 14k

    Total Downloads

  • 36k

    Total Views and Downloads

About this Research Topic

Submission closed

Background

Immune checkpoint inhibitors (ICI) have become a focus and hope for the future in cancer therapy, while the potential of ICI for the treatment of chronic infections is only beginning to be assessed. The heterogeneity and complexity of cancers make ICI favorable to be developed as personalized medicine to suit individual needs. However, not every patient has benefited as response rates are still inadequate and ICIs are limited by immune-related adverse events and toxicities as well as complications from increased risk of infection. These failures may be due to immune variations from aging as well as genetic differences such as sex. 
Sex hormones, including estrogen, progesterone, and androgens, are steroid hormones with a substantial impact on the immune system. Estrogen demonstrates both pro- and anti-inflammatory roles while progesterone and androgens are mainly anti-inflammatory. Sex hormones share a common biosynthetic pathway with glucocorticoids, a group of strong anti-inflammatory agents in the body, which predicts interactions with consequences on immune response. 
In addition, the sex chromosomes also harbor many other immune-related genes. Toll-like receptors, cytokine receptors involved in T-cell and B-cell activity are localized to the X chromosome and inflammatory pathway genes in Y.  These sex-based immunological differences contribute to variations in incidence of immune-related conditions such as autoimmune and cardiovascular diseases. Females defend better against infectious diseases and possibly malignancies and have superior respond to vaccines. Clearly, variations are expected in other immune-based therapies including ICIs.
Early studies on the efficacy of ICI suggest males respond better, achieving improved overall survival (OS) and progression-free survival (PFS) from therapy with PD-1/PD-L1 inhibitors in melanoma and NSCLC. Increased frequencies of PD-1 expressing CD4+ T cells among males may be a contributory factor. 
Aging, on the other hand, impairs immunity with the production of new immune cells beginning to diminish, a higher basal level of inflammatory factors in the elderly promoting inflammatory diseases in the cardiovascular system and neurodegenerative diseases, reducing the ability to fight cancers and infections.
Thus, age and sex may alter the intensity of immune response, increasing or decreasing thresholds to cross over, which are crucial in deciding the final outcome in immune-based treatment modalities. Indeed, the elderly appear to tolerate ICI similar to younger patients but lower efficacy has been seen in certain cancers. 
Nevertheless, we may only be scratching the surface with these targets as the immune system is complex and well known for its redundancy and multiplicity. New targets may extend to innate immunity as the cells are just as capable to fight cancers and infections and respond under regulation and control. Ultimately, in our efforts to retrain the immune system to regain its protective ability against cancers and infections, it is worthwhile to consider also the need to overcome age and sex factors.
In this Research Topic we welcome authors to submit Reviews, Mini-Reviews, Original Research, Perspective, and Clinical Trial articles focusing on, but not limited to, the following subtopics:
1) Molecular/cellular immune checkpoint differences due to age or sex2) Role of sex hormones in differential efficacy of Immune Checkpoint Inhibitors3) Sex-differences in the immune response and adverse reactions to Immune Checkpoint Inhibitors4) Age-related immune differences in affecting outcome of immune checkpoint inhibitors5) Safety and efficacy of ICI in elderly people with cancers and infections such as malaria, HIV, HBV or SARS-CoV-2 

Important note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.

Frequently asked questions

  • Frontiers' Research Topics are collaborative hubs built around an emerging theme.Defined, managed, and led by renowned researchers, they bring communities together around a shared area of interest to stimulate collaboration and innovation.

    Unlike section journals, which serve established specialty communities, Research Topics are pioneer hubs, responding to the evolving scientific landscape and catering to new communities.

  • The goal of Frontiers' publishing program is to empower research communities to actively steer the course of scientific publishing. Our program was implemented as a three-part unit with fixed field journals, flexible specialty sections, and dynamically emerging Research Topics, connecting communities of different sizes and maturity.

    Research Topics originate from the scientific community. Many of our Research Topics are suggested by existing editorial board members who have identified critical challenges or areas of interest in their field.

  • As an editor, Research Topics will help you build your journal, as well as your community, around emerging, cutting-edge research. As research trailblazers, Research Topics attract high-quality submissions from leading experts all over the world.

    A thriving Research Topic can potentially evolve into a new specialty section if there is sustained interest and a growing community around it.

  • Each Research Topic must be approved by the specialty chief editor, and they fall under the editorial oversight of our editorial boards, supported by our in-house research integrity team. The same standards and rigorous peer review processes apply to articles published as part of a Research Topic as for any other article we publish.

      In 2023, 80% of the Research Topics we published were edited or co-edited by our editorial board members, who are already familiar with their journal's scope, ethos, and publishing model. All other topics are guest edited by leaders in their field, each vetted and formally approved by the specialty chief editor.

  • Publishing your article within a Research Topic with other related articles increases its discoverability and visibility, which can lead to more views, downloads, and citations. Research Topics grow dynamically as more published articles are added, causing frequent revisiting, and further visibility.

    As Research Topics are multidisciplinary, they are cross-listed in several fields and section journals – increasing your reach even more and giving you the chance to expand your network and collaborate with researchers in different fields, all focusing on expanding knowledge around the same important topic.

    Our larger Research Topics are also converted into ebooks and receive social media promotion from our digital marketing team.

  • Frontiers offers multiple article types, but it will depend on the field and section journals in which the Research Topic will be featured. The available article types for a Research Topic will appear in the drop-down menu during the submission process.

    Check available article types here 

  • Yes, we would love to hear your ideas for a topic. Most of our Research Topics are community-led and suggested by researchers in the field. Our in-house editorial team will contact you to talk about your idea and whether you’d like to edit the topic. If you’re an early-stage researcher, we will offer you the opportunity to coordinate your topic, with the support of a senior researcher as the topic editor. 

    Suggest your topic here 

  • A team of guest editors (called topic editors) lead their Research Topic. This editorial team oversees the entire process, from the initial topic proposal to calls for participation, the peer review, and final publications.

    The team may also include topic coordinators, who help the topic editors send calls for participation, liaise with topic editors on abstracts, and support contributing authors. In some cases, they can also be assigned as reviewers.

  • As a topic editor (TE), you will take the lead on all editorial decisions for the Research Topic, starting with defining its scope. This allows you to curate research around a topic that interests you, bring together different perspectives from leading researchers across different fields and shape the future of your field. 

    You will choose your team of co-editors, curate a list of potential authors, send calls for participation and oversee the peer review process, accepting or recommending rejection for each manuscript submitted.

  • As a topic editor, you're supported at every stage by our in-house team. You will be assigned a single point of contact to help you on both editorial and technical matters. Your topic is managed through our user-friendly online platform, and the peer review process is supported by our industry-first AI review assistant (AIRA).

  • If you’re an early-stage researcher, we will offer you the opportunity to coordinate your topic, with the support of a senior researcher as the topic editor. This provides you with valuable editorial experience, improving your ability to critically evaluate research articles and enhancing your understanding of the quality standards and requirements for scientific publishing, as well as the opportunity to discover new research in your field, and expand your professional network.

  • Yes, certificates can be issued on request. We are happy to provide a certificate for your contribution to editing a successful Research Topic.

  • Research Topics thrive on collaboration and their multi-disciplinary approach around emerging, cutting-edge themes, attract leading researchers from all over the world.

  • As a topic editor, you can set the timeline for your Research Topic, and we will work with you at your pace. Typically, Research Topics are online and open for submissions within a few weeks and remain open for participation for 6 – 12 months. Individual articles within a Research Topic are published as soon as they are ready.

    Find out more about our Research Topics

  • Our fee support program ensures that all articles that pass peer review, including those published in Research Topics, can benefit from open access – regardless of the author's field or funding situation.

    Authors and institutions with insufficient funding can apply for a discount on their publishing fees. A fee support application form is available on our website.

  • In line with our mission to promote healthy lives on a healthy planet, we do not provide printed materials. All our articles and ebooks are available under a CC-BY license, so you can share and print copies.